Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dung T Le

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advancesDung T Le, Elizabeth M Jaffee
The Journal of Clinical Investigation|October 2, 2018
DNA repair defects and implications for immunotherapyKatherine M Bever, Dung T Le
The New England Journal of Medicine|March 11, 2021
Microsatellite-Instability-High Advanced Colorectal Cancer. ReplyLuis A Diaz, Dung T Le, Thierry André
Advances in Cancer Research|June 21, 2021
Immunotherapy in colorectal cancerParul Agarwal, Dung T Le, Patrick M Boland
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2023
Immunotherapy of MSI Cancer: Facts and HopesH Catherine Wilbur, Dung T Le, Parul Agarwal
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Tissue-Agnostic Drug DevelopmentKeith T Flaherty, Dung T Le, Steven Lemery
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Cellular vaccine approachesDung T Le, Drew M Pardoll, Elizabeth M Jaffee
Seminars in Oncology|May 19, 2012
Clinical development of Listeria monocytogenes-based immunotherapiesDung T Le, Thomas W Dubenksy, Dirk G Brockstedt
The Oncologist|July 15, 2016
Mismatch Repair Deficiency and Response to Immune Checkpoint BlockadeValerie Lee, Adrian Murphy, Dung T Le, et al.
Cancer Metastasis Reviews|April 4, 2025
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the uglyJacob J Adashek, Jillian A Moran, Dung T Le, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
Next-generation cancer vaccine approaches: integrating lessons learned from current successes with promising biotechnologic advancesDung T Le, Elizabeth M Jaffee
The Journal of Clinical Investigation|October 2, 2018
DNA repair defects and implications for immunotherapyKatherine M Bever, Dung T Le
The New England Journal of Medicine|March 11, 2021
Microsatellite-Instability-High Advanced Colorectal Cancer. ReplyLuis A Diaz, Dung T Le, Thierry André
Advances in Cancer Research|June 21, 2021
Immunotherapy in colorectal cancerParul Agarwal, Dung T Le, Patrick M Boland
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 28, 2023
Immunotherapy of MSI Cancer: Facts and HopesH Catherine Wilbur, Dung T Le, Parul Agarwal
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Tissue-Agnostic Drug DevelopmentKeith T Flaherty, Dung T Le, Steven Lemery
Cancer Journal (Sudbury, Mass.)|August 10, 2010
Cellular vaccine approachesDung T Le, Drew M Pardoll, Elizabeth M Jaffee
Seminars in Oncology|May 19, 2012
Clinical development of Listeria monocytogenes-based immunotherapiesDung T Le, Thomas W Dubenksy, Dirk G Brockstedt
The Oncologist|July 15, 2016
Mismatch Repair Deficiency and Response to Immune Checkpoint BlockadeValerie Lee, Adrian Murphy, Dung T Le, et al.
Cancer Metastasis Reviews|April 4, 2025
Lessons learned from a decade of immune checkpoint inhibition: The good, the bad, and the uglyJacob J Adashek, Jillian A Moran, Dung T Le, et al.
Pageof 13